Vannucchi Alessandro Maria

121PUBLICATIONS
298CO-AUTHORS
Haematological tumoursGene and molecular therapyPredictive and prognostic markersMedical infection agents (incl. prions)Medical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (121)

|Aug 20, 2026
Impact of cytoreductive therapy in myeloproliferative neoplasm-associated splanchnic vein thrombosis.

|Jul 11, 2026
Cancer history and second cancer risk in polycythemia vera and essential thrombocythemia.

|Apr 29, 2026
The lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat in myelofibrosis: results from a phase 1/2 study.

|Mar 06, 2026
Genomic structural variations contribute to inform prognosis in patients with cytogenetically normal acute myeloid leukemia.

Niccolò Bartalucci, Francesco Mannelli, Danilo Tarantino

|Mar 05, 2026
Genomic profiling for decision-making in post-polycythemia vera and post-essential thrombocythemia myelofibrosis.

Barbara Mora, Francesca Palandri, Paola Guglielmelli

|Mar 04, 2026
Myeloid/lymphoid neoplasms with FGFR1 rearrangement and pemigatinib.

Alessandro M Vannucchi, Jay L Patel, Jean-Jacques Kiladjian

Pageof 21

Frequent Collaborators

49 joint publications

Paola Guglielmelli

35 joint publications

Giuseppe Gaetano Loscocco

35 joint publications

Ayalew Tefferi

31 joint publications

Tiziano Barbui